SCHEMBL24763274

SCHEMBL24763274

Cc1oc2cc(C#N)c(F)cc2c(=O)c1CN(CCCc1cccnc1)Cc1ccncc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA5 P22460 10/20 0.39
▸ KCNJ1 P48048 1/20 0.38
▸ IGLV6-57 P01721 3/20 0.38
▸ KCNJ5 P48544 5/20 0.38
▸ KCNJ3 P48549 5/20 0.38
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC9 Q9UKV0 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36
▸ NR1D1 P20393 3/20 0.35
▸ NR1H3 Q13133 3/20 0.35
▸ BCHE P06276 1/20 0.33
▸ MAOA P21397 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21591460 0.89 KCNA5 (0.40) KCNA5IGLV6-57KCNJ5KCNJ3HDAC3
SCHEMBL21591520 0.86 HDAC3 (0.41) KCNA5IGLV6-57KCNJ5KCNJ3HDAC3
SCHEMBL21591555 0.83 KCNA5 (0.40) KCNA5IGLV6-57KCNJ5KCNJ3HDAC3
SCHEMBL21592245 0.83 KCNA5 (0.38) KCNA5IGLV6-57KCNJ5KCNJ3HDAC3
SCHEMBL21592279 0.83 KCNA5 (0.44) KCNA5IGLV6-57KCNJ5KCNJ3HDAC3
SCHEMBL21591526 0.83 PDE3B (0.39) KCNA5IGLV6-57KCNJ5KCNJ3HDAC3
SCHEMBL21591552 0.82 KCNA5 (0.41) KCNA5IGLV6-57KCNJ5KCNJ3HDAC3
SCHEMBL21591564 0.78 GPR119 (0.37) KCNA5IGLV6-57KCNJ5KCNJ3
SCHEMBL21591500 0.77 HDAC3 (0.41) KCNA5IGLV6-57KCNJ5KCNJ3HDAC3
SCHEMBL31361801 0.77 HDAC3 (0.41) KCNA5IGLV6-57KCNJ5KCNJ3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12162863-B2 Modulators of stimulator of interferon genes (STING) Ryvu Therapeutics S.A. (PL) 2024-12-10 — — US disclosed
US-20220402898-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-12-22 — — US disclosed
US-20220402898-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12162863-B2 Modulators of stimulator of interferon genes (STING) STING1, IRF3, CGAS KCNA5 2592/4885KCNJ1 2137/4885IGLV6-57 2946/4885
US-20220402898-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) STING1, IRF3, CGAS KCNA5 2592/4885KCNJ1 2137/4885IGLV6-57 2946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback